Signal log.

This is a sell-side analyst rating/price target update — UBS maintaining Neutral on TEAM with a raised PT from $95 to $160. It conveys no new information about Atlassian's SoR capabilities, MCP integration, agent infrastructure posture, or any of the five thesis pillars; it is purely a valuation opinion.

A major analyst downgrade is a financial sentiment event, not a product or strategy signal for HubSpot's CRM SoR thesis. It cuts against market conviction but provides no evidence of change to HubSpot's records/state/ownership/queryable-history pillars.

Okta's explicit targeting of 'nonhuman identity' for AI agents directly supports the thesis that identity & permissions systems are becoming the agent control plane (Bucket 8). The news shows a SoR platform monetising the agent shift rather than being displaced.

The headline reports a price target raise and maintained Hold rating from TD Cowen — a purely financial/valuation analyst action. It contains no information about Atlassian's SoR capabilities, agent infrastructure, MCP server, or any of the five thesis pillars.

This is a sell-side price target upgrade for JFrog, reflecting analyst sentiment and valuation, but contains no information about JFrog's role as a system of record, its state machine capabilities, agent integrations, or any of the five thesis pillars. It is financially relevant but thesis-neutral.

The headline reports that Antipodes trimmed its position in Workday despite strong cash flow, which is a bearish signal for the stock. This directly cuts against the thesis that Workday (an HRIS/ERP SoR) will benefit from agent-driven consolidation and monetisation.

The headline discusses a technical chart pattern (golden cross) for MANH stock, which is a price-momentum signal with no bearing on Manhattan Associates' role as a systems-of-record platform or its agent-economy positioning. No thesis pillar is addressed.

Wells Fargo maintains an Overweight rating on Atlassian and raises its price target from $140 to $180, signaling strong analyst conviction in the company's prospects. This directly supports the thesis that Atlassian (a leader in the Dev work/issue tracking SoR bucket) is positioned to benefit from agent adoption, as positive analyst sentiment often correlates with expected platform consolidation and monetization tailwinds.

A disappointing outlook and revenue guidance cut at HubSpot signals operational hiccups, which cuts against the thesis that SoR platforms like CRM systems will compound as agent substrate; a weakening growth trajectory would reduce the company's ability to invest in agent-era infrastructure.